Rodolfo Guardado-Mendoza
Universidad de Guanajuato
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rodolfo Guardado-Mendoza as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:03 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07297589 · Epicardial Cardiac Fat-CT (EPIC-CT)Instituto Mexicano del Seguro Social · recruiting · STEMI - ST Elevation Myocardial Infarction, Epicardial Fat · study chair
- Ph3NCT07295223 · Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)Instituto Mexicano del Seguro Social · completed · Acute Myocardial Infarction With ST Elevation · principal investigator
- N/ANCT04717986 · Dapagliflozin Effects on Mayor Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction (DAPA-AMI)Instituto Mexicano del Seguro Social · completed · Acute Myocardial Infarction, Cardiovascular Morbidity, Heart Failure
- Ph3NCT04134650 · Effect of Low Dose Combination of Linagliptin + Metformin to Prevent DiabetesUniversidad de Guanajuato · unknown · Prediabetic State, Insulin Resistance · principal investigator
- Ph3NCT04131582 · Effect of Empagliflozin + Linagliptin + Metformin + Lifestyle in Patients With PrediabetesUniversidad de Guanajuato · unknown · Prediabetic State, Insulin Resistance · principal investigator
- Ph4NCT04088461 · Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With MetformineUniversidad de Guanajuato · completed · Prediabetic State, Impaired Glucose Tolerance, Insulin Resistance
- Ph4NCT03004612 · Effect of Linagliptin + Metformin vs Metformin Alone in Patients With PrediabetesUniversidad de Guanajuato · completed · Prediabetic State, Insulin Resistance · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:03 UTC. The ranking covers the 200 most relevant of 9 PubMed records, and a shared surname and initials can bring in a namesake. All 9 on PubMed
- The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial.Metabolism · 202026 citationsRCR 1.2
- 14 citationsRCR 1.1
- Effect of a family and interdisciplinary intervention to prevent T2D: randomized clinical trial.BMC Public Health · 202011 citationsRCR 0.8
- Islet amyloid polypeptide response to maximal hyperglycemia and arginine is altered in impaired glucose tolerance and type 2 diabetes mellitus.Acta Diabetol · 20178 citationsRCR 0.3
- 6 citationsRCR 0.4
- Clinical and Metabolic Characteristics among Mexican Children with Different Types of Diabetes Mellitus.PLoS One · 20164 citationsRCR 0.2
- Effect of vitamin K1 supplementation on coronary calcifications in hemodialysis patients: a randomized controlled trial.J Nephrol · 20254 citationsRCR 2.0
- Safety of the oral methionine load test: effects on the clinical performance and laboratory tests.Rev Invest Clin · 20131 citationsRCR 0.1
- Dapagliflozin in acute myocardial infarction with type 2 diabetes: a randomized clinical trial.Curr Probl Cardiol · 2026